Onkologie. 2008:2(2):79-81
Conformal radiotherapy in head and neck cancer therapy
- 1 Ústav radiační onkologie 1. LF UK a FN na Bulovce, Praha
- 2 Klinika radiační onkologie FN Ostrava
3D conformal radiotherapy is the standart modality for the treatment head and neck cancer today. Next expansion of the IMRT is expectable, but in some cases the 3D confomal radiotherapy will have the importance in the future probablly. 3D confomalt radiotherapy is based on the comlex procedure including planinng CT, conturing of treatment planning volume and organs at risk for the optimal constituion of shaped field by multileaf colimator, after that follow the simulation of tratment technique and the verification in the treatment room. Radiotherpay is the treatment modality very sensitive to quality assurance. The effective use of accelerated and hyperfracionated radioherapy is possibleš, when preciouse quality assurance is performed. 2D radiotherapy is supposed to be very obsolent today.
Keywords: radiotherapy, head and neck cancer, acceleration, hyperfractionation
Published: August 1, 2008 Show citation
References
- Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000 Mar 18; 355(9208): 949-955.
Go to original source... - Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007; 85: 156-170. Go to original source...
Go to PubMed... - Bourhis J, Overgaard J, Audry H et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a metaanalysis. The Lancet 2006; 368: 843-854. Go to original source... Go to PubMed...
- Cellai E, Frata P, Magrini SM et al. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5): 1378-1386. Go to original source... Go to PubMed...
- Horiot JC, Le Fur R, N'Guyen T et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992 Dec; 25(4): 231-241. Go to original source... Go to PubMed...
- Yao M, Dornfeld KJ, Buatti JM et al. Int. J. Radiation Oncology Biol. Phys. 2005, 63(2): 410-421. Go to original source... Go to PubMed...
- Fu KK, Pajak TF, Trotti A, Jones CU et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000 Aug 1; 48(1): 7-16. Go to original source... Go to PubMed...
- Overgaard JHansen HS, Specht L, Overgaard M et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003 Sep 20; 362(9388): 933-940. Go to original source... Go to PubMed...
- Skladowski K, Maciejewski B, Golen M, Tarnawski R et al. Continuous accelerated 7 days-aweek radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys. 2006 Nov 1; 66(3): 706-713. Go to original source... Go to PubMed...
- Terhaard CH, Kal HB, Hordijk GJ. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Int J Radiat Oncol Biol Phys. 2005 May 1; 62(1): 62-69. Go to original source... Go to PubMed...